Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$19.09 - $22.57 $96,977 - $114,655
5,080 Added 28.81%
22,715 $445,000
Q1 2024

May 03, 2024

BUY
$21.55 - $29.29 $5,064 - $6,883
235 Added 1.35%
17,635 $382,000
Q4 2023

Feb 08, 2024

BUY
$23.64 - $30.27 $2,931 - $3,753
124 Added 0.72%
17,400 $503,000
Q3 2023

Nov 09, 2023

SELL
$26.74 - $40.81 $6,364 - $9,712
-238 Reduced 1.36%
17,276 $461,000
Q2 2023

Aug 07, 2023

SELL
$28.52 - $40.7 $4,962 - $7,081
-174 Reduced 0.98%
17,514 $648,000
Q1 2023

May 01, 2023

BUY
$29.39 - $36.27 $130,138 - $160,603
4,428 Added 33.39%
17,688 $552,000
Q4 2022

Feb 07, 2023

SELL
$29.23 - $40.28 $38,788 - $53,451
-1,327 Reduced 9.1%
13,260 $395,000
Q3 2022

Oct 25, 2022

BUY
$37.92 - $63.74 $12,854 - $21,607
339 Added 2.38%
14,587 $556,000
Q2 2022

Aug 08, 2022

BUY
$47.98 - $62.75 $24,037 - $31,437
501 Added 3.64%
14,248 $777,000
Q1 2022

May 06, 2022

SELL
$49.85 - $96.11 $11,664 - $22,489
-234 Reduced 1.67%
13,747 $858,000
Q4 2021

Feb 08, 2022

SELL
$77.3 - $105.0 $16,464 - $22,365
-213 Reduced 1.5%
13,981 $1.41 Million
Q3 2021

Oct 28, 2021

BUY
$74.87 - $110.87 $75,543 - $111,867
1,009 Added 7.65%
14,194 $1.28 Million
Q2 2021

Jul 27, 2021

BUY
$66.8 - $100.45 $1,736 - $2,611
26 Added 0.2%
13,185 $1.22 Million
Q1 2021

May 03, 2021

BUY
$59.3 - $183.85 $156,196 - $484,260
2,634 Added 25.03%
13,159 $1.27 Million
Q4 2020

Feb 04, 2021

SELL
$31.01 - $52.1 $6,170 - $10,367
-199 Reduced 1.86%
10,525 $548,000
Q3 2020

Nov 06, 2020

BUY
$15.89 - $50.51 $170,404 - $541,669
10,724 New
10,724 $429,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $506M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Texas Permanent School Fund Portfolio

Follow Texas Permanent School Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.